NKT Therapeutics' Series B Round

NKT Therapeutics raised a round of funding on August 16, 2010.

NKT Thereapeutics develops therapeutics based on a subset of immune cells called natural killer T cells.…

Articles about NKT Therapeutics' Series B Round: